Skip to main content
. Author manuscript; available in PMC: 2017 Mar 10.
Published in final edited form as: Ann Intern Med. 2016 Jun 21;165(5):345–355. doi: 10.7326/M16-0065

Table 2.

Diagnostic accuracy by HCV core antigen (HCVcAg) index test type for diagnosis of active HCV infection compared to nucleic acid testing as the reference standard. Results from bivariate, univariate, range of studies, and single studies are all reported.

Index Test HCV Ab Status # Studies (# Samples) Sensitivity 95% CI Specificity 95% CI Positive LR 95% CI Negative LR 95% CI
Abbott ARCHITECT1 All 23 (12,670) 93.4%1 (90.1, 96.5) 98.8%1 (97.4, 99.5) 80.6 (36.4, 178.8) 0.06 (0.04, 0.1)
Abbott ARCHITECT2 All 33 (13,638) 94.3%2 (92.8, 95.9) ND NA NA
Abbott ARCHITECT1 Known Ab Positive 16 (5,246) 92.5%1 (86.9, 95.8) 97.8%1 (94.7, 99.1) 42 (16.4, 106.4) 0.05 (0.03, 0.08)
Abbott ARCHITECT2 Known Ab positive 27 (6,189) 93.4%2 (91.4, 95.4) ND NA NA
Abbott ARCHITECT1 Known Ab Negative 5 (3,415) 92.3%1 (3.7, 99.9) 98.8%1 (97.3, 99.4) 73.9 (32.6, 167.9) 0.08 (0.004, 15.7))
Ortho ELISA-Ag1 All 5 (1,177) 93.2%1 (81.6, 97.7) 99.2%1 (87.9, 100) 116.5 (6.7, 977) 0.06 (0.02, 0.07)
Ortho ELISA-Ag2 All 6 (1,423) 90.8%2 (83.5, 98.2) ND NA NA
EIKEN Lumispot HCV Ag3 All 2 (235) 97.5–98.1%3 ND NA NA
Fujirebio Lumipulse Ortho HCV Ag4 All 1 (80) 95.0%4 (90.2, 99.8) ND NA NA
Hunan Jynda Bioengineering Group HCV Core Ag ELISA1 All 4 (562) 59.5%1 (46.0, 71.7) 82.9%1 (58.6, 94.3) 3.5 (1.1, 12.6) 0.28 (0.2, 0.3)

HCV = Hepatitis C Virus, cAg = Core Antigen, Ab = Antibody, CI = Confidence Interval, LR = likelihood ratio, ELISA = enzyme linked immunosorbent assay, ND = no data, NA = Not applicable—if sensitivity and specificity results were not available from meta-analysis, likelihood ratios were not calculated.

1

Determined by bivariate meta-analysis – “metandi” command in STATA

2

Determined by univariate meta-analysis – “metan” command in STATA

3

Meta-analysis not possible, range of results seen across studies reported

4

Results from one study only